On Tuesday, IDEXX Laboratories Inc. (NASDAQ:IDXX) shares closed at $457.38, marking a 1.58% increase, breaking the company's two-day losing streak. This rise came in contrast to the broader stock market downturn, with the S&P 500 Index and the Dow Jones Industrial Average falling by 0.22% and 0.31%, settling at 4,443.95 and 34,517.73 respectively.
Despite Tuesday's gains, IDEXX Laboratories' closing price still trails its 52-week high of $564.74 achieved on July 27th by $107.36.
In terms of performance on Tuesday, IDEXX Laboratories outperformed some of its competitors in the healthcare sector. Johnson & Johnson's (NYSE:NYSE:JNJ) shares decreased by 0.17%, closing at $162.20, while Medtronic PLC (NYSE:NYSE:MDT) saw a slight fall of 0.21% to $82.63. On the contrary, Boston Scientific Corp.'s (NYSE:NYSE:BSX) shares rose marginally by 0.06%, ending at $53.03.
Trading volume for IDEXX Laboratories was recorded at 414,989 on Tuesday, approximately 52,057 below its average trading volume over the past 50 days—467,046.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.